2can: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="2can" size="450" color="white" frame="true" align="right" spinBox="true" caption="2can, resolution 2.30Å" /> '''HUMAN ORNITHINE AMI...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:2can.gif|left|200px]]<br />
[[Image:2can.gif|left|200px]]<br /><applet load="2can" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="2can" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="2can, resolution 2.30&Aring;" />
caption="2can, resolution 2.30&Aring;" />
'''HUMAN ORNITHINE AMINOTRANSFERASE COMPLEXED WITH L-CANALINE'''<br />
'''HUMAN ORNITHINE AMINOTRANSFERASE COMPLEXED WITH L-CANALINE'''<br />


==Overview==
==Overview==
BACKGROUND: Ornithine aminotransferase (OAT) is a 45 kDa, pyridoxal-5'-phosphate (PLP)-dependent enzyme that catalyzes the, conversion of L-ornithine and 2-oxoglutarate to, glutamate-delta-semialdehyde and glutamic acid, respectively. In humans, loss of OAT function causes an accumulation of ornithine that results in, gyrate atrophy of the choroid and retina, a disease that progressively, leads to blindness. In an effort to learn more about the structural basis, of this enzyme's function, we have determined the X-ray structures of OAT, in complex with two enzyme-activated suicide substrates: L-canaline, an, ornithine analog, and gabaculine, an irreversible inhibitor of several, related aminotransferases. RESULTS: The structures of human OAT bound to, the inhibitors gabaculine and L-canaline were solved to 2.3 A at 110K by, difference Fourier techniques. Both inhibitors coordinate similarly in the, active site, binding covalently to the PLP cofactor and causing a 20, degrees rotation in the cofactor tilt relative to the ligand-free form., Aromatic-aromatic interactions occur between the bound gabaculine molecule, and active-site residues Tyr85 and Phe177, whereas Tyr55 and Arg180, provide specific contacts to the alpha-amino and carboxyl groups of, L-canaline. CONCLUSIONS: The OAT-L-canaline complex structure implicates, Tyr55 and Arg180 as the residues involved in coordinating with the natural, substrate ornithine during normal enzyme turnover. This correlates well, with two enzyme-inactivating point mutations associated with gyrate, atrophy, Tyr55--&gt;His and Arg180--&gt;Thr. The OAT-gabaculine complex provides, the first structural evidence that the potency of the inhibitor is due to, energetically favourable aromatic interactions with residues in the active, site. This aromatic-binding mode may be relevant to structure-based drug, design efforts against other omega-aminotransferase targets, such as GABA, aminotransferase.
BACKGROUND: Ornithine aminotransferase (OAT) is a 45 kDa pyridoxal-5'-phosphate (PLP)-dependent enzyme that catalyzes the conversion of L-ornithine and 2-oxoglutarate to glutamate-delta-semialdehyde and glutamic acid, respectively. In humans, loss of OAT function causes an accumulation of ornithine that results in gyrate atrophy of the choroid and retina, a disease that progressively leads to blindness. In an effort to learn more about the structural basis of this enzyme's function, we have determined the X-ray structures of OAT in complex with two enzyme-activated suicide substrates: L-canaline, an ornithine analog, and gabaculine, an irreversible inhibitor of several related aminotransferases. RESULTS: The structures of human OAT bound to the inhibitors gabaculine and L-canaline were solved to 2.3 A at 110K by difference Fourier techniques. Both inhibitors coordinate similarly in the active site, binding covalently to the PLP cofactor and causing a 20 degrees rotation in the cofactor tilt relative to the ligand-free form. Aromatic-aromatic interactions occur between the bound gabaculine molecule and active-site residues Tyr85 and Phe177, whereas Tyr55 and Arg180 provide specific contacts to the alpha-amino and carboxyl groups of L-canaline. CONCLUSIONS: The OAT-L-canaline complex structure implicates Tyr55 and Arg180 as the residues involved in coordinating with the natural substrate ornithine during normal enzyme turnover. This correlates well with two enzyme-inactivating point mutations associated with gyrate atrophy, Tyr55--&gt;His and Arg180--&gt;Thr. The OAT-gabaculine complex provides the first structural evidence that the potency of the inhibitor is due to energetically favourable aromatic interactions with residues in the active site. This aromatic-binding mode may be relevant to structure-based drug design efforts against other omega-aminotransferase targets, such as GABA aminotransferase.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
2CAN is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with CAN as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Ornithine_aminotransferase Ornithine aminotransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.6.1.13 2.6.1.13] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2CAN OCA].  
2CAN is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=CAN:'>CAN</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Ornithine_aminotransferase Ornithine aminotransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.6.1.13 2.6.1.13] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2CAN OCA].  


==Reference==
==Reference==
Line 18: Line 17:
[[Category: Ornithine aminotransferase]]
[[Category: Ornithine aminotransferase]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Brunger, A.T.]]
[[Category: Brunger, A T.]]
[[Category: Shah, S.A.]]
[[Category: Shah, S A.]]
[[Category: Shen, B.W.]]
[[Category: Shen, B W.]]
[[Category: CAN]]
[[Category: CAN]]
[[Category: ornithine aminotransferase]]
[[Category: ornithine aminotransferase]]
Line 27: Line 26:
[[Category: urea cycle]]
[[Category: urea cycle]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 21:13:22 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:46:41 2008''